Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles
Abstract The blood‐brain barrier (BBB), which protects the brain from foreign molecules, makes delivery of drugs to the central nervous system is challenging. Nanoparticles (NPs) have been used over the past decade as drug delivery systems for the treatment of many disorders with great results. Howe...
Saved in:
| Main Authors: | Ramesha Hanumanthappa, Aravind Parthasarathy, Geetha B. Heggannavar, Kiran PC, Hemalatha Nanjaiah, Ramhari Kumbhar, Kuramkote Shivanna Devaraju |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Neuroprotection |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/nep3.60 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stress enhances expression of calcium‐binding proteins and NMDAR subunit genes in the rat hippocampus
by: Aravind Parthasarathy, et al.
Published: (2024-06-01) -
A Levodopa-Encapsulated Poly-ε-Caprolactone Nanocomposite Improves the Motor Symptoms and Neurochemical Changes in a Rotenone-Induced Mouse Model of Parkinson’s Disease
by: Ramesha Hanumanthappa, et al.
Published: (2025-05-01) -
Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's
by: Ahsas Goyal, et al.
Published: (2025-03-01) -
Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer’s and Parkinson’s disease
by: Sofia Toniolo, et al.
Published: (2025-05-01) -
Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
by: Eleftheria-Emmanouela Katsoulaki, et al.
Published: (2025-06-01)